---
figid: PMC3720596__oncotarget-04-494-g001
figtitle: NRAS mutant melanoma – undrugable?
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC3720596
filename: oncotarget-04-494-g001.jpg
figlink: /pmc/articles/PMC3720596/figure/F1/
number: F1
caption: 'Wild type NRAS (top left) cycles between an inactive GDP-bound and active
  GTP-bound state, whereas mutations in G12, G13 and Q61 prevent hydrolysis of GTP,
  locking mutant NRAS in its GTP-bound, active state (top right) which results in
  permanent, stimulus independent downstream signaling. NRAS-GTP activates downstream
  effectors of the MAPK and PI3K/mTOR pathway (dark blue boxes). Schematic of the
  cell cycle pathway (light blue) and interaction sites of the specific inhibitors
  in the different cascades (red lines). (RTK: receptor tyrosine kinases, GAP: GAPase
  activating protein, GEF: guanosine exchange factor, MEKi: MEK inhibitor, PI3K/mTORi:
  PI3K/mTOR inhibitor, CDKi4,6: CDK4,6 inhibitor)'
papertitle: NRAS mutant melanoma – undrugable?.
reftext: Christian Posch, et al. Oncotarget. 2013 Apr;4(4):494-495.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9596441
figid_alias: PMC3720596__F1
figtype: Figure
redirect_from: /figures/PMC3720596__F1
ndex: dc1472a5-ded1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3720596__oncotarget-04-494-g001.html
  '@type': Dataset
  description: 'Wild type NRAS (top left) cycles between an inactive GDP-bound and
    active GTP-bound state, whereas mutations in G12, G13 and Q61 prevent hydrolysis
    of GTP, locking mutant NRAS in its GTP-bound, active state (top right) which results
    in permanent, stimulus independent downstream signaling. NRAS-GTP activates downstream
    effectors of the MAPK and PI3K/mTOR pathway (dark blue boxes). Schematic of the
    cell cycle pathway (light blue) and interaction sites of the specific inhibitors
    in the different cascades (red lines). (RTK: receptor tyrosine kinases, GAP: GAPase
    activating protein, GEF: guanosine exchange factor, MEKi: MEK inhibitor, PI3K/mTORi:
    PI3K/mTOR inhibitor, CDKi4,6: CDK4,6 inhibitor)'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nras
  - Arhgef2
  - Sergef
  - Rap1gap
  - Rasa1
  - Cdkn1a
  - Cdkn1c
  - Pik3r1
  - Zhx2
  - Prkca
  - Mdk
  - Cdkn2a
  - Ccnd1
  - Cdk4
  - Akt1
  - Ephb2
  - Mapk1
  - Mtor
  - Pck1
  - Pik3cg
  - Defb1
  - Ephb1
  - Ccne1
  - NRAS
  - ARHGEF2
  - SLC2A4RG
  - RASA1
  - RGS6
  - MTG1
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PRKCA
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - CDKN2A
  - CCND1
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - MTOR
  - hh
  - Tie
  - Ras85D
  - InR
  - PDZ-GEF
  - garz
  - RhoGEF64C
  - pbl
  - Gapdh2
  - CdGAPr
  - Gapdh1
  - RasGAP1
  - ArfGAP1
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - Dsor1
  - Mtk
  - Akt
  - Erk7
  - rl
  - rb
  - ebi
  - E2f2
  - E2f1
  - Tor
  - CycE
  - cyc
  - Cancer
  - Lung cancer
---
